Optimization via experimental design of an SPE-HPLC-UV-fluorescence method for the determination of valsartan and its metabolite in human plasma samples

Journal of Separation Science

Volumn 29, Issue 15, 2006, Pages 2265-2283

  Iriarte, Gorka ^a   Ferreirós, Nerea ^a   Ibarrondo, Izaskun ^a   Alonso, Rosa Maria ^a   Maguregi, Miren Itxaso ^a   Gonzalez, Lorena ^a   Jiménez, Rosa Maria ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Experimental design; Human plasma; SPE HPLC; Valeryl 4 hydroxy valsartan; Valsartan

Indexed keywords

BODY FLUIDS; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLITES; OPTIMIZATION; ULTRAVIOLET SPECTROSCOPY;

CENTRAL COMPOSITE DESIGN; FRACTIONAL FACTORIAL DESIGN; HUMAN PLASMA; VALSARTAN;

DRUG PRODUCTS;

ACETONITRILE; CANDESARTAN; DRUG METABOLITE; ETHER; METHANOL; PHOSPHATE; VALSARTAN;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; ELUTION; EXPERIMENTAL DESIGN; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; SOLID PHASE EXTRACTION; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; TETRAZOLES; VALINE;

EID: 33750455117     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.200600093     Document Type: Article

References (57)

1. Flesch, G., Muller, P. H., Lloyd, P., Eur. J. Clin. Pharmacol. 1997, 52, 115-120.
2. Criscione, L., Bradley, W., Buhlmayer, P., Whitebread, S., et al., Cardio vasc. Drug Rev. 1995, 13, 230-250.
3. Oparil, S., Dyke, S., Harris, F., Kief, J., et al., Clin. Ther. 1996, 18, 797-810.
4. Markham, A., Goa, K. L., Drugs 1997, 54, 299-311.
5. Young, C. H., Zhang, K., Poret, A. W., Am. J. Health-Syst. Pharm. 2005, 62, 2381-2385.
6. Fuenfstueck, R., Hempel, R.-D., Ansari, A., Weidinger, G., Klebs, S., Adv. Ther. 2005, 22, 263-277.
7. Rossing, K., Jacobsen, P. K., Hansen, B. V., Carstensen, B., Parving, H.-H., Diabetes Care 2003, 26, 150-155.
8. Nakao, N., Yoshimura, A., Morita, M., Kayano, T., Ideura, T., Lancet 2003, 361, 117-124.
9. McMurray, J. J. V., Östergren, J., Swedberg, K., Granger, C. B., et al., Lancet 2003, 362, 767-771.
10. Russo, D., Minutolo, R., Pisani, A., Esposito, R., et al., Am. J. Kidney Dis. 2001, 38, 18-25.
11. Struckman, D., Rivey, M., Michael, P., Ann. Pharmacother. 2001, 35, 242-248.
12. Kuriyama, S., Tomonari, H., Abe, A., Imasawa, T., Hosoya, T., Nephron 2000, 86, 529-530.
13. Campbell, R., Sangalli, F., Perticucci, E., Aros, C., et al., Kidney Int. 2003, 63, 1094-1103.
14. Hebert, L. A., Falkenhain, M., Nohman, N., Cosio, F. G., O'Dorisio, T. M., Am. J. Nephrol. 1999, 19, 1-6.
15. Latini, R., Masson, S., Staszewsky, L., Maggioni, A. P., Expert Opin. Pharmacother. 2004, 5, 181-193.
16. Young, J. B., Dunlap, M. F., Pfeffer, M. A., Probstfield, J. L., et al., Circulation 2004, 110, 2618-2626.
17. Alcocer, L., Fernandez-Bonetti, P., Campos, E., Ruiz, R. C., et al., Int. J. Clin. Pract. 2004, 145(Suppl.), 35-39.
18. Andreadis, E. A., Tsourous, G. L, Marakomichelakis, G. E., Katsanou, P. M., et al. J. Hum. Hypertens. 2005, 19, 491-496.
19. Okura, T., Higaki, J., Ketsuatsu 2005, 12, 1060-1064.
20. Vachiery, J. L., Rev. Med. Bruxelles 2003, 24, A249-A252.
21. Waldmeier, F., Flesch, G., Müller, P., Winkler, T., et al., Xenobiotica 1997, 27, 59-71.
22. Eicher, T., Hauptmann, S., The Chemistry of Heterocycles: Structure, Reactions, Synthesis and Applications, Georg Thieme Verlag, Sttutgart 1995.
23. Guibault, G. G., Practical Fluorescence, Marcel Dekker, New York 1990.
24. Zhang, J., Chen, S., Gu, T., Lu, X., Hu, Y., Shanghai Dier Yike Daxue Xuebao 2004, 24, 133-135, 142.
25. Gonzalez, L., Alonso, R. M., Jimenez, R. M., Chromatographia 2000, 52, 735-740.
26. Macek, J., Klíma, J., Ptácek, P., J. Chromatogr. B 2006, 832, 169-172.
27. Daneshtalab, N., Lewanczuk, R. Z., Jamali, F., J. Clin. Pharmacol. 2004, 44, 245-252.
28. Gonzalez, L., Lopez, J. A., Alonso, R. M., Jimenez, R. M., J. Chromatogr. A 2002, 949, 49-60.
29. Daneshtalab, N., Lewanczuk, R. Z., Jamali, F., J. Chromatogr. B 2002, 766, 345-349.
30. Séchaud, R., Graf, P., Bigler, H., Gruendi, E., et al., Int. J. Clin. Pharmacol. Ther. 2002, 40, 35-40.
31. Xu, Y., Cao, W., Lin, X., Ling, S., Zhongguo Yaolixue Tongbao 2002, 18, 586-588.
32. Li, Y., Zhao, Z., Chen, X., Wang, J., et al., Yaowu Fenxi Zazhi 2000, 20, 404-406.
33. Schmidt, E. K., Antonin, K.-H., Flesch, G., Racine-Poon, A., Eur. J. Clin. Pharmacol. 1998, 53, 451-458.
34. Sioufi, A., Marfil, F., Godbillon, J., J. Liq. Chromatogr. 1994, 17, 2179-2186.
35. Brunner, L. A., Powell, M. L., Degen, P., Flesch, G., Lab. Robotics Automat. 1994, 6, 171-179.
36. Maurer, H. H., Kraemer, T., Arlt, J. W., Ther. Drug Monit. 1998, 20, 706-713.
37. Cagigal, E., Gonzalez, L., Alonso, R. M., Jimenez, R. M., Talanta 2001, 54, 1121-1133.
38. Esbensen, K. H., Multivariate Data in Analysis in Practice, Camo, Denmark 2001.
39. Bayne, C. K., Rubin, I. B., Practical Experimental Designs and Optimization Methods for Chemists, VCH, Wenheim. 1986.
40. Morgan, E., Chemometrics-Experimental Design, Wiley, Chichester 1991.
41. Preu, M., Petz, M., J. Chromatogr. A 1999, 840, 81-91.
42. Box, G. E. P., Hunter, W. G., Hunter, J. S., Statistics for Experiments An Introduction to Design, Data Analysis and Model Building, John Wiley & Sons, New York 1978.
43. Goupy, J., Methods for Experimental Design, Principles and Applications for Physicists and Chemists, Elsevier, Amsterdam 1992.
44. Siouffi, A. M., Phan-Tan-Luu, R., J. Chromatogr. A 2000, 892, 75-106.
45. Shan, Y., Seidel-Morgenstern, A., J. Chromatogr. A 2005, 1093, 47-58.
46. Cutroneo, P., Beljean, M., Phan-Tan-Luu, R., Siouffi, A. M., J. Pharm. Biomed. 2006, 41, 333-340.
47. Gonzalez, L., Akesolo, U., Jimenez, R. M., Alonso, R. M., Electrophoresis 2002, 23, 223-229.
48. Miyabayashi, T., Okuda, T., Motohashi, M., Izawa, K., Yashiki, T., J. Chromatogr. B 1996, 677, 123-132.
49. Cagigal, E., Gonzalez, L., Alonso, R. M., Jimenez, R. M., J. Pharm. Biomed. 2001, 26, 477-486.
50. Snyder, L. R., Glajch, J., Kirkland, J. J., Practical HPLC Method Development, John Wiley & Sons, New York 1989.
51. Dos Ramos, F. G., J. Chromatogr. A 2000, 888, 69-83.
52. Stenhoff, H., Lagerström, P. O., Andersen, C., J. Chromatogr. B 1999, 731, 411-417.
53. Lundberg, D. E., Jr., Person, R. C., Knox, S., Cyronak, M. J., J. Chromatogr. B 1998, 707, 328-333.
54. Yeung, P. K. F., Jamieson, A., Smith, G. J., Fice, D., Pollak, P. T., Int. J. Pharm. 2000, 204, 17-22.
55. Torrealday, N., Gonzalez, L., Alonso, R. M., Jimenez, R. M., Ortiz Lastra, E., J. Pharm. Biomed. 2003, 32, 847-857.
56. Muller, P., Flesch, G., de Gasparo, M., Gasparini, M., Howald, H., Eur. J. Clin. Pharmacol. 1997, 52, 441-449.
57. Sioufi, A., Marfil, F., Jaouen, A., Cardot, J. M. et al., Biopharm. Drug Dispos. 1998, 19, 237-244.